User profiles for Sergiusz Wesołowski
 | Sergiusz Wesołowski, PhDUniversity of Utah, Center of Genetic Discovery Verified email at genetics.utah.edu Cited by 192 |
[HTML][HTML] An explainable artificial intelligence approach for predicting cardiovascular outcomes using electronic health records
Understanding the conditionally-dependent clinical variables that drive cardiovascular
health outcomes is a major challenge for precision medicine. Here, we deploy a recently …
health outcomes is a major challenge for precision medicine. Here, we deploy a recently …
[HTML][HTML] De novo and recessive forms of congenital heart disease have distinct genetic and phenotypic landscapes
WS Watkins, EJ Hernandez, S Wesolowski… - Nature …, 2019 - nature.com
The genetic architecture of sporadic congenital heart disease (CHD) is characterized by
enrichment in damaging de novo variants in chromatin-modifying genes. To test the hypothesis …
enrichment in damaging de novo variants in chromatin-modifying genes. To test the hypothesis …
Stochasticity and time delays in evolutionary games
J Miȩkisz, S Wesołowski - Dynamic games and applications, 2011 - Springer
We discuss combined effects of stochasticity and time delays in simple evolutionary games
with a unique mixed evolutionarily stable strategy. We present three models of time-delay …
with a unique mixed evolutionarily stable strategy. We present three models of time-delay …
[HTML][HTML] A comparison of methods for RNA-seq differential expression analysis and a new empirical Bayes approach
Transcriptome-based biosensors are expected to have a large impact on the future of
biotechnology. However, a central aspect of transcriptomics is differential expression analysis, …
biotechnology. However, a central aspect of transcriptomics is differential expression analysis, …
A Poisson binomial-based statistical testing framework for comorbidity discovery across electronic health record datasets
G Lemmon, S Wesolowski, A Henrie… - Nature computational …, 2021 - nature.com
Discovering the concomitant occurrence of distinct medical conditions in a patient, also known
as comorbidities, is a prerequisite for creating patient outcome prediction tools. Current …
as comorbidities, is a prerequisite for creating patient outcome prediction tools. Current …
Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine …
Purpose Progression from metastatic castration-sensitive prostate cancer (mCSPC) to a
castration-resistant (mCRPC) state heralds the lethal phenotype of prostate cancer. Identifying …
castration-resistant (mCRPC) state heralds the lethal phenotype of prostate cancer. Identifying …
Comprehensive genomic profiling of cell-free DNA in men with advanced prostate cancer: differences in genomic landscape based on race
…, U Swami, A Kessel, E Jaeger, S Wesolowski… - The …, 2022 - academic.oup.com
Advanced prostate cancer (aPC) in Black men was reported to present with aggressive
features and to be associated with poor prognosis. Herein, we compared the cell-free DNA (…
features and to be associated with poor prognosis. Herein, we compared the cell-free DNA (…
Shape-based data analysis for event classification in power systems
Fault classification in power systems is a challenging and complex task as the variety and
variability of the electrical parameters of the various network components in spatial and …
variability of the electrical parameters of the various network components in spatial and …
[HTML][HTML] Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling of cell-free …
BRCA1-mutated prostate cancer has been shown to be less responsive to poly (ADP-ribose)
polymerase (PARP) inhibitors as compared to BRCA2-mutated prostate cancer. The …
polymerase (PARP) inhibitors as compared to BRCA2-mutated prostate cancer. The …
Differences in the tumor genomic landscape between African Americans (AA) and Caucasians (CA) advanced prostate cancer (aPC) patients (pts) by comprehensive …
…, U Swami, A Kessel, E Jaeger, S Wesolowski… - 2021 - ascopubs.org
5058 Background: Emerging data suggest differences in the tumor genomic profile of AA
compared with CA men with aPC. We hypothesized that there will be significant differences in …
compared with CA men with aPC. We hypothesized that there will be significant differences in …